‘The price is bewildering’: The cost of Biogen’s Alzheimer’s drug may lead payers to erect roadblocks

June 7, 2021
STAT News

Related news

In the news

December 19, 2022

How to Ascend in Your Career (With Erin Feigal)

People Make it Possible podcast

In the news

December 16, 2022

Prime Therapeutics joins other PBMs in adding Humira biosimilars

Becker’s Payer Issues